A comprehensive review on Pueraria: Insights on its chemistry and medicinal value - 28/10/20
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 17 |
| Iconographies | 4 |
| Vidéos | 0 |
| Autres | 0 |
Graphical abstract |
Highlights |
• | Pueraria is being used in food, cosmetic, and pharmaceutical industries. |
• | Bioactivities of Pueraria are mainly due to isoflavones. |
• | Puerarin is a marker compound of the Pueraria genus. |
• | Puerarin received an investigational drug status for the treatment of alcohol abuse. |
• | Pueraria has beneficial effects in postmenopausal women & CHD patients. |
Abstract |
Pueraria species are listed in the Chinese Pharmacopeia and are being used for the treatment of various health ailments and in protecting health. Puerarin, a chemotaxonomic marker of Pueraria, received investigational drug status for the treatment of alcohol abuse and listed in DRUGBANK database. The purpose of this review is to provide insights on health benefits of Pueraria, its bioactive constituents and molecular mechanisms. The information is retrieved from various databases. The most investigated plant part is tuber and the major bioactive constituents are isoflavones. The Pueraria is reported to possess a lots of health benefits on brain, liver, heart, kidney, bone, stomach, muscle, skin, and reproductive system. Pueraria also shown beneficial effects in postmenopausal women. In this review, the scientific information on Pueraria reported until May 2020 were analysed and summarized logically to appreciate its health benefits and to identify research gaps.
Le texte complet de cet article est disponible en PDF.Keywords : Pueraria, Kudzu, Isoflavones, Phytoestrogens, Puerarin, Alcohol abuse
Plan
Vol 131
Article 110734- novembre 2020 Retour au numéro
Article précédent
- New understanding of the pathogenesis and treatment of stroke-related sarcopenia
- Wei Li, Tao Yue, Yanming Liu
- Male predisposition to severe COVID-19: Review of evidence and potential therapeutic prospects
- Desmond Omane Acheampong, Isaac Kyei Barffour, Alex Boye, Enoch Aninagyei, Stephen Ocansey, Martin Tangnaa Morna
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?